Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermatopharmacokinetic Trial of LEO 80185 Gel vs Dovobet Ointment
NCT02605057Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Nov 2015
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of AKP01 and betamethasone dipropionate spray 0.05% in Psoriasis vulgaris (PV) (2 arms), sponsored by LEO Pharma. Primary endpoints: The amount of calcipotriol in the stratum corneum at 24 hours and The amount of betamethasone dipropionate in the stratum corneum at 24 hours. Started Nov 2015; status: completed.
02
Drugs
AKP01betamethasone dipropionate spray 0.05%
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT02605057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605057.